Antibody therapies for the prevention and treatment of viral infections

Antibody therapies for the prevention and treatment of viral infections

Post Views: 169 The recent and still ongoing pandemic of Covid-19 shook the world in ways unimaginable. Labs worldwide were urged to find therapies to prevent and treat this deadly viral infection. Today one often hears the word ‘antibodies’ mentioned during this disease’s treatment and recovery phase. But, What are antibodies?What are the antibody therapies?What…

Monoclonal Antibody Therapy for COVID-19

Monoclonal Antibody Therapy for COVID-19

Post Views: 127 Monoclonal antibodies are laboratory-created proteins that replicate the immune system’s capacity to combat diseases such as SARS-CoV-2. Furthermore, SARS-CoV-2, like other infectious organisms, can change over time, resulting in specific therapies failing to act against particular variations, such as the Omicron. Monoclonal antibodies are medicinal agents being researched to treat COVID-19. These…

Does a Covid infection guarantee protective antibodies?

Does a Covid infection guarantee protective antibodies?

Post Views: 234 Among the most extraordinary questions of the overwhelming COVID-19 pandemic is the toughness of resistance and time to likely reinfection. There is restricted direct information on SARS-CoV-2 long-term immune responses and reinfection. Antibodies are essential for the body’s immune response to infection. Antibodies that neutralise SARS-CoV-2, which causes COVID-19, are typically recognisable…

Neutralizing Antibodies for the COVID-19 treatment

Neutralizing Antibodies for the COVID-19 treatment

Post Views: 627 The severe acute respiratory syndrome, also known as SARS-CoV-2 or the Covid-19 has caused unusual global health and economic dilemmas. Numerous vaccine strategies and repurposed drugs are currently under evaluation for safety and efficiency. Meanwhile, diverse neutralizing monoclonal antibodies (nMAbs) targeting SARS-CoV-2 spike glycoprotein are in diverging stages of clinical trials and…